EUCTR2005-001086-34-DK进行中（未招募）不适用
A randomised trial of 6 months versus 12 months withdrawal of methotrexate in patients with juvenile idiopathic arthritis in clincal remission - MTX withdrawal study
ISTITUTO GIANNINA GASLINI-PRINTO0 个研究点目标入组 200 人开始时间: 2005年8月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients will be included at first confirmation of remission on medication, i.e. after clinically documented inactive disease. At the time remission is documented patients may be ONLY on a combination of non-steroidal anti-inflammatory drugs (NSAIDs), and MTX (max 15 mg/m2/week). All the other drugs (eg biologics, steroids etc) must have been withdrawn before this date according to the physician decision; specifically steroid must have been withdrawn at least 1 month before remission is documented and other drugs (biologics, other DMARDs, intraarticular joint injections etc) at least 3 months before remission is documented. At inclusion into this study patients will be considered being in clinically documented remission on medication.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Treatment with steroids in the month before remission is first documented. Treatment with biologics, other DMARDs, intraarticular joint injections etc in the 3 months before remission is first documented
研究者
相似试验
已完成
不适用
A randomised trial of 6 months versus 12 months withdrawal of methotrexate in patients with Juvenile Idiopathic Arthritis (JIA) in clinical remissioJuvenila Idiopathic Arthritis (JIA)Musculoskeletal DiseasesJuvenila idiopathic arthritisISRCTN18186313Pediatric Rheumatology International Trials Organisation (PRINTO) (Italy) and Wyeth Pharma300
进行中（未招募）
不适用
A randomised trial of 6 months versus 12 months withdrawal of methotrexate in patiebts with juvenile idiopathic arthritis in clinical remission.Ensayo aleatorizado de retirada de Metotrexate a los 6 meses versus a los 12 meses, en pacientes con Artritis Idiopática Juvenil (AIJ) en remisión clínica - MTX withdrawal studyThe present study was designed for the follow up of two groups of patients with JIA, in whom remission was achieved using MTX. In group 1 treatment with MTX will be discontinued as early as 6 months after documentation of remission on medication. In group 2 treatment with MTX will be discontinued later than 12 mpnths after documentation of remission on medication.EUCTR2005-001086-34-ESIstituto Giannina Gaslini-PRINTO200
进行中（未招募）
不适用
A randomised Phase III trial of 6 months versus 12 months withdrawal of methotrexate in patients with juvenile idiopathic arthritis in clinical remissioMedDRA version: 6.1Level: PTClassification code 10059177juvenile idiopathic arthritisEUCTR2005-001086-34-ITISTITUTO GIANNINA GASLINI
招募中
不适用
TB Duration StudyCTRI/2020/03/023957Hyderabad Eye Resesarch Foundation
已完成
2 期
Randomized trial of clinical effect of 6 months or 3months Gn-RH agonist (Goserelin acetate 1.8mg) to endometriosis comlicated uterine myomaJPRN-UMIN000026073Department of Obstetrics and Gynecology Nara Medical University80